期刊文献+

复方活血灵预防骨折后深静脉血栓的抗炎与抗氧化机制 被引量:10

Study on anti-inflammatory and antioxidant mechanism of compound huoxue ling in preventing deep vein thrombosis after fracture
原文传递
导出
摘要 目的探讨方剂活血灵(HXL)预防骨折后深静脉血栓的抗炎、抗氧化作用机制。方法60只1个月龄Wister大鼠随机平均分成空白组(予以纯化水10ml/kg)、对照组(予以纯化水10ml/kg)、阳性药物组(予以阿司匹林116.9mg/kg)、中药HXL低、中、高(含生药量0.625、1.230、2.460s/ml的水溶液)每组各10只,采用创伤性造模方法制备大鼠下肢深静脉血栓;各组在造模前7d给药,每天1次,于造模后第7天取用各组大鼠腹腔血液检测血流变及相关凝血指标,并采用酶联免疫吸附测定(ELISA)组织中白细胞介素-1(IL-1)、白细胞介素-6(IL-6)、肿瘤坏死因子-α(TNF-α)水平改变;取发生血栓处静脉组织,采用生化法检测活性氧簇(ROS)水平、超氧化物歧化酶(SOD)活力、谷胱甘肽过氧化物酶(GSH-Px)、丙二醛(MDA)含量。结果阳性药物组活化部分凝血活酶时间(APTT)、血浆凝血酶原时间(PT)、凝血酶时间(TT)、D.二聚体(D-dimer)值分别为[(19.10±0.54)、(8.61±0.56)、(17.76±0.58)s、(52.82±2.66)μg/L]与HXL高剂量组[(21.534±0.34)、(9.16±0.30)、(18.75±0.41)s、(46.89±1.64)μg/L]比较,差异有统计学意义(P=0.003、0.001、0.002、0.001),HXL高剂量组对凝血指标APTT、PT、TY、D-dimer改善优于阳性药物组;阳性药物组IL-1、TNF-α、IL-6水平分别为356.27±24.41、250.89±24.77、152.71±11.36,与HXL高剂量组(297.32±17.86、240.23±23.15、145.834±10.94)比较,HXL高剂量组与阳性药物组IL-1差异有统计学意义(P=0.000);阳性药物组ROS、SOD、GSH-Px、MDA值分别为(34297.38±302.44)、(110.40±11.32)、(221.05±19.67)U/L、(11.024±1.15)mmol/L,与HXL高剂量组[(31704.244±272.12)、(114.92±11.72)、(ZZ8.65±15.18)U/L、(8.97±0.97)mmol/L]比较,HXL高剂量组与阳性药物组ROS水平比较,两组差异有� Objective To explore the mechanism of anti-inflammatory and anti-oxidation effects of prescription Huoxueling (HXL) in preventing deep vein thrombosis after fracture. Methods Sixty Wistar rats aged one month were randomly divided into blank group (purified water 10 ml/kg) , control group (purified water 10 ml/kg), positive drug group (aspirin 116. 9 mg/kg), and Chinese medicine HXL. Low-, medium-, and high-strength (containing crude drug amounts of 0.625, 1.230 and 2.460 g/ml aqueous solutions) of 10 rats in each group were used to prepare rat deep venous thrombosis using a traumatic model; 7 days before the injection of the mould, once a day, on the 7th day after the injection, the blood of the rats in each group was used to measure the blood rheology and related coagulation indexes, and the interleukin in the tissue was detected by enzyme-linked immunosorbent assay (ELISA). interleukin -1(IL-1), interleukin -6 (IL-6), and tumor necrosis factor-α ( TNF-α) levels were changed ; biochemical methods were used to detect the level of reactive oxygen species (ROS) in the venous venous tissue. Superoxide dismutase (SOD) activity, glutathione peroxidase (GSH-Px), malondi-aldehyde (MDA) content. Results The activated partial thromboplastin time (APTF) , plasma prothrombin time (PT), thrombin time (TF), and D-dimer were (19. 10 ±0. 54) s in the positive drug group [(8.61±0.56), (17.76 ±0.58) s, (52.82±2.66) μg/L) and HXLhigh-dose groups [(21.53±0. 34), (9.16 ±0. 30), (18.75 ±0. 41) s, (46. 89 ± 1.64) μg/L] Significance (P =0. 003, 0. 001, 0. 002, 0. 001 ) , HXL high-dose group had better improvement of coagulation indexes APTT, PT, TF, and D-dimer than positive drug group ; positive drug group IL-1, TNF-α, IL-6 levels were 356. 27 ± 24. 41, 250. 89±24.77, 152. 71±11.36 and HXL high-dose groups (297. 32± 17. 86, 240. 23 ± 23.15, 145.83 ± 10. 94 ) , respectively. High-and low-dose HXL groups were posi
作者 郭珈宜 李峰 范仪铭 崔宏勋 郭艳幸 Guo Jiayi;Li Fertg;Fan Yiming;Cui Hongxun;Guo Yanxing(Department of Orthopedics,Luoyang Bone-setting Hospital,Luoyang 471002,China)
出处 《中华实验外科杂志》 CAS CSCD 北大核心 2018年第11期2017-2019,共3页 Chinese Journal of Experimental Surgery
基金 国家中医药管理局“平乐郭氏正骨流派传承工作室”建设项目([2012]228) 河南省中医药管理局“河南省中医临床学科领军人才培育计划”项目(HNzYU20131009) 2016年河南省科技发展计划项目(162102310365)
关键词 活血灵 深静脉血栓 炎症 氧化应激 预防 Huoxueling Deep vein thrombosis Inflammation Oxidative stress Prevention
  • 相关文献

参考文献1

二级参考文献17

  • 1NORDSTOM M, LINDBLAD B, BERGQVIST D,et al. A prospective study of the incidence of deepvein thrombosis within a defined urban Impulation[J]. J Intern Med, 1992, 232:155. 被引量:1
  • 2SILVERSTEIN M D, HEIT J A, MOHR D N, et al. Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25 - year populationbased study [J]. Arch Intern Med, 1998, 158:585. 被引量:1
  • 3THOMAS D P, MERTON R E, WOOD R E, et al.The relationship between vessel wall injury and venous thrombosis: An experimental study [J ]. Br J Haematol, 1985, 59 (1) : 449. 被引量:1
  • 4KURZ K D, MAIN B W, SANDUSKY G E. Rat model of arterial thrombosis induced by ferric chloride[J]. Thromb Res, 1990, 60 (2) : 269. 被引量:1
  • 5CLAGETT G P, REISC J S. Prevention of venous thromboembolism in general surgical patients: result of Meta analysis [J]. Ann Surg, 1988, 208 (2).227. 被引量:1
  • 6HENKE P K, WAKEFIELD T W, KADELL A M,et al. Luter Leukin C8 administration enhances venous thrombosis in a rat model [J]. J Surg Res, 2001,99 (1): 84. 被引量:1
  • 7REYERS I, MUSSONI L, DONATI M B, et al.Failure of aspirin at different doses to modify experimental thrombosis in rats [J]. Thromb Res, 1980,18 (5): 669. 被引量:1
  • 8THOMAS D P, MERTON R E, HOCKLY R J.The effect of stasis on the venous endothelium: An ultrastructural study [ J ]. Br J Haematol, 1983,55 (1): 113. 被引量:1
  • 9BERNHARD V M, GELFORD E T, CORHRAN G A, et al. Isolated arteriovenous limb perfusion in experimental iliofemoral venous thrombosis [ J ].Curt Topics Surg Res, 1970, 2: 503. 被引量:1
  • 10STALLWORTH J M, NAJIB A, KLETKE R R,et al. Phlegmasia cerulea dolens: an experimental study [J]. Ann Surg, 1976, 165:860. 被引量:1

共引文献14

同被引文献145

引证文献10

二级引证文献114

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部